From pixels to prognosis: A QUADAS-2-Guided systematic review and meta-analysis of deep learning segmentation for DLBCL in PET and PET/CT.
Abstract
This systematic review and meta-analysis evaluated the performance and methodological quality of deep learning models for automated segmentation of Diffuse Large B-Cell Lymphoma (DLBCL) on PET/CT imaging. A comprehensive literature search identified 15 eligible studies that were published up to July 2025. Of these, 11 studies were included in the quantitative synthesis, while 4 were assessed qualitatively. Using a random-effects model, the pooled mean DSC was 0.809 (95% CI: 0.791-0.827), indicating strong overall segmentation performance. The reported DSC values across the individual studies ranged from 0.65 to 0.886. Single-center studies generally showed slightly higher median DSC values (≈0.82) than multi-center studies (≈0.78), although pooled subgroup analyses revealed comparable averages (0.77 vs. 0.73). Methodological quality, assessed using the QUADAS-2 tool, showed that most studies (approximately 67-73%) were at low risk of bias, with the remainder classified as moderate or unclear. Despite the variability in algorithms, study designs, and datasets, DL-based methods have consistently achieved reliable segmentation accuracy. Overall, DL models demonstrated promising potential for automated DLBCL segmentation in PET/CT imaging. Nevertheless, future studies should focus on larger and more diverse cohorts, improved reporting standards, and transparent handling of methodological limitations to enhance generalizability and clinical applicability.
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Learning from First-Generation Qualitative Approaches in the IS Discipline: An Evolutionary View and Some Implications for Authors and Evaluators (PART 1/2)
- Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models
- Prosthesis: New Technological Opportunities and Innovative Biomedical Devices
- The history and future of neural modeling for cochlear implants
- Ryanodine receptors: waking up from refractoriness
- Novel Transgenic Rabbit Model Sheds Light on the Puzzling Role of Matrix Metalloproteinase-12 in Atherosclerosis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.